glp-1 syringe analogues for obesity? How to measure dosages? :

However, cardiovascular safety trials in type 2 diabetes patients, the majority presenting cardiovascular disease and excess weight, showed that GLP-1 receptor agonists were indeed capable of decreasing cardiovascular risk

So-called GLP-1 patches have gained popularity through social media marketing as a needle-free alternative to prescription weight loss injections

PMID: 32013116

You may be a fit if you have a BMI of 27+ (or 25+ with a weight-related condition), have struggled to lose weight through diet and exercise alone, want a clinically-studied medication with provider supervision, or want a clinically-studied, long-established GLP-1 medication

WeightWatchers stock is down more than 88% since the beginning of the year